NCT00064870

Brief Summary

The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Jun 2002

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
Jun 2002Jul 2026

Study Start

First participant enrolled

June 1, 2002

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

July 14, 2003

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 16, 2003

Completed
23 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

October 1, 2025

Status Verified

April 1, 2025

Enrollment Period

24.1 years

First QC Date

July 14, 2003

Last Update Submit

September 26, 2025

Conditions

Keywords

Alzheimer diseaseLate Onset Alzheimer disease risk factor genesGeneticsInitiativeDementia

Outcome Measures

Primary Outcomes (1)

  • Distribute biological specimens to qualified investigators for use in their research studies.

    Investigators will analyze the samples and publish de-identified results. These publications will help to further the knowledge in the field of dementia and potentially lead to new therapies and targets for therapies.

    Contact investigators annually for an update on progress and publication status.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Families with two or more members with Alzheimer's disease or dementia

You may qualify if:

  • Two living family members diagnosed with AD or other dementia with any age of onset
  • Biological samples available
  • Fresh blood, or
  • Immortalized lymphoblastic cell lines, or
  • grams of frozen cerebral cortex; fixed samples are not accepted
  • Please note: this study does not include genetic counseling; because no personal identifying information such as name or date of birth is attached to samples, results of individual tests are not available to participants or family members.

You may not qualify if:

  • Member of a family that was included in the National Institute of Mental Health AD Genetics Sib Pair collection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Participants are being recruited from all over the United States

Nationwide, Indiana, 46202, United States

RECRUITING

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

blood samples, brain tissue, cell lines

MeSH Terms

Conditions

Alzheimer DiseaseDementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Tatiana M. Foroud, PhD

    National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), Indiana University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Coordinator

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department Chair

Study Record Dates

First Submitted

July 14, 2003

First Posted

July 16, 2003

Study Start

June 1, 2002

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

October 1, 2025

Record last verified: 2025-04

Locations